Creative Medical Technology Holdings Inc (CELZ)

[uvaphd]

By way of context: all my criticisms of mgmt are predicated on the belief that they plan to bring products to commercial market, rather than selling them—they have always said this. If, however, they were planning to sell, e.g. CaverStem, they WOULD want to wait for this week’s release, a future publication on short and long term efficacy, AND several Qs worth of fins in order to determine a fair valuation baseline.